Understanding probabilistic risk in predisposition genetic testing for Alzheimer disease

Area of Science:

• Neuroscience
• Genetics
• Health Psychology

Background:

• Genetic testing for Alzheimer disease (AD) aims to identify individuals at risk for preventive interventions.
• Current prevention strategies for AD are not yet proven effective.
• The utility of genetic testing hinges on accurate risk stratification.

Purpose of the Study:

• To explore the limitations of risk stratification in genetic medicine for AD prevention.
• To examine how individuals understand and respond to genetic risk information.
• To critique the process of generating and communicating genetic risk estimates.

Main Methods:

• Review of cognitive and health psychology research on understanding uncertainty.
• Analysis of social science critiques of risk concepts in genetic medicine.
• Exploration of the patient experience of "embodied risk" in genetic testing.

Main Results:

• The paradigm of disease prevention through risk stratification has unexplored limitations.
• Limited research exists on how individuals comprehend genetic risk for AD.
• The process of creating risk estimates and patient responses are under-examined.

Conclusions:

• Informed choices about genetic testing for AD may be more complex than current ethical models suggest.
• A broader perspective is needed, considering both the production of risk estimates and individual patient experiences.
• Further research is required to understand the nuances of genetic risk communication and decision-making.